tiprankstipranks
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market
KLRS
Kalaris Therapeutics
RESEARCH TOOLSreports

Kalaris Therapeutics (KLRS) Income Statement

374 Followers

Kalaris Therapeutics Income Statement

Last quarter (Q4 2025), Kalaris Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Kalaris Therapeutics's net income was $-10.00M. See Kalaris Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -13.00K$ 0.00$ 0.00$ 0.00$ -1.12M
Operating Expenses
$ 46.14M$ 55.26M$ 13.46M$ 14.01M$ 168.70M
Depreciation and Amortization
$ 13.00K$ 0.00$ 0.00$ 0.00$ 1.12M
EBITDA
$ -46.14M$ -58.77M$ -14.01M$ -15.25M$ -169.84M
Operating Income
$ -46.15M$ -55.26M$ -13.46M$ -14.01M$ -169.82M
Other Income/Expenses
$ 2.71M$ -3.51M$ -1.24M$ -1.48M$ -1.14M
Pretax Income
$ -43.44M$ -58.77M$ -14.70M$ -15.48M$ -170.96M
Net Income
$ -43.44M$ -58.77M$ -14.70M$ -15.48M$ -171.96M
Per Share Metrics
Basic EPS
$ -2.85$ -11.73$ -42.09$ -50.62$ -63.00
Diluted EPS
$ -2.85$ -11.73$ -42.09$ -50.62$ -63.00
Weighted Average Shares Outstanding
 15.27M 5.01M 4.52M 3.33M 2.73M
Weighted Average Shares Outstanding (Diluted)
 15.27M 5.01M 4.52M 3.33M 2.73M
Currency in USD

Kalaris Therapeutics Earnings and Revenue History